R&D Grants for funding pharmaceutical research: Growing without ... Whilst equity investment is likely to be central to the funding strategy of many early-stage biotechs, grant funding can be a very useful alternative.
Patients Providing patient access to new therapies, with Dean Erhardt Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.